Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2009 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting

Study NCT00513578 Information provided by National Cancer Institute (NCI)

First Received on August 6, 2007. Last Updated on February 26, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Preleukemia

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial

The Vaccine Company